Chemical pneumonitis natural history, complications, and prognosis

Revision as of 01:15, 2 November 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...)
Jump to navigation Jump to search

Chemical pneumonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Chemical pneumonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chemical pneumonitis natural history, complications, and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chemical pneumonitis natural history, complications, and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chemical pneumonitis natural history, complications, and prognosis

CDC onChemical pneumonitis natural history, complications, and prognosis

Chemical pneumonitis natural history, complications, and prognosis in the news

Blogs on Chemical pneumonitis natural history, complications, and prognosis

Directions to Hospitals Treating Chemical pneumonitis

Risk calculators and risk factors for Chemical pneumonitis natural history, complications, and prognosis

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]

Overview

Prognosis

  • Approximately, 3 in 5 patients have clinical improvement with clearing of chest Xray.
  • Approximately, 1 in every 3rd patient shows a rapid improvement followed with a new progressive infiltrate suggesting secondary superimposed bacterial infection or the development of ARDS.
  • The least common course but with worst prognosis is the development of fulminant disease resulting in acute death.

References

Template:WH Template:WS